[HTML][HTML] Multiple sclerosis, a treatable disease
A Doshi, J Chataway - Clinical Medicine, 2017 - Elsevier
This article reviews our current understanding and modern treatment of multiple sclerosis
(MS). MS is a disabling condition resulting in devastating social and economic impacts. As …
(MS). MS is a disabling condition resulting in devastating social and economic impacts. As …
Highly active multiple sclerosis: An update
C Díaz, LA Zarco, DM Rivera - Multiple sclerosis and related disorders, 2019 - Elsevier
Multiple sclerosis (MS) is the most prevalent chronic inflammatory disease of the central
nervous system (CNS), affecting more than 2 million people worldwide. It is characterized by …
nervous system (CNS), affecting more than 2 million people worldwide. It is characterized by …
Severe, highly active, or aggressive multiple sclerosis
MS Freedman, CA Rush - CONTINUUM: Lifelong Learning in …, 2016 - journals.lww.com
Abstract Purpose of Review: Despite the efficacy of current therapies for relapsing forms of
multiple sclerosis (MS), there remains a group of patients whose disease fails to respond …
multiple sclerosis (MS), there remains a group of patients whose disease fails to respond …
Relapsing and progressive forms of multiple sclerosis: insights from pathology
R Dutta, BD Trapp - Current opinion in neurology, 2014 - journals.lww.com
Available therapies for multiple sclerosis patients, while effective during the relapsing phase,
have little benefit for progressive multiple sclerosis patients. Development of therapies to …
have little benefit for progressive multiple sclerosis patients. Development of therapies to …
Therapeutic advances and challenges in the treatment of progressive multiple sclerosis
LE Baldassari, RJ Fox - Drugs, 2018 - Springer
Despite the fact that majority of patients with multiple sclerosis (MS) have relapsing-remitting
disease, many transition to secondary progressive disease (SPMS) over time. This transition …
disease, many transition to secondary progressive disease (SPMS) over time. This transition …
Secondary progressive multiple sclerosis: new insights
In most cases, multiple sclerosis (MS) begins with a relapsing-remitting course followed by
insidious disability worsening that is independent from clinically apparent relapses and is …
insidious disability worsening that is independent from clinically apparent relapses and is …
Advances in the treatment of multiple sclerosis
C Goldschmidt, MP McGinley - Neurologic clinics, 2021 - neurologic.theclinics.com
Multiple sclerosis (MS) is an immune-mediated, inflammatory demyelinating disease of the
central nervous system (CNS) that leads to irreversible disability and currently is estimated …
central nervous system (CNS) that leads to irreversible disability and currently is estimated …
Management of multiple sclerosis relapses
P Repovic - CONTINUUM: Lifelong Learning in Neurology, 2019 - journals.lww.com
Management of Multiple Sclerosis Relapses : CONTINUUM: Lifelong Learning in Neurology
Account Register Activate Subscription Help Subscribe American Academy of Neurology …
Account Register Activate Subscription Help Subscribe American Academy of Neurology …
Primary progressive multiple sclerosis: progress and challenges
Primary progressive multiple sclerosis (MS) has long been recognised as presenting great
difficulties to our management of what is increasingly a treatable neurological disease. Here …
difficulties to our management of what is increasingly a treatable neurological disease. Here …
Multiple sclerosis—a quiet revolution
RM Ransohoff, DA Hafler, CF Lucchinetti - Nature Reviews Neurology, 2015 - nature.com
Multiple sclerosis (MS) has been thought to be a complex and indecipherable disease, and
poorly understood with regards to aetiology. Here, we suggest an emphatically positive view …
poorly understood with regards to aetiology. Here, we suggest an emphatically positive view …